Differential BK channel potentiation by vanzacaftor enantiomers enables therapy for modulator-ineligible people with cystic fibrosis
Nathalie Baumlin, … , Frank T. Horrigan, Matthias Salathe
Nathalie Baumlin, … , Frank T. Horrigan, Matthias Salathe
Published August 7, 2025
Citation Information: J Clin Invest. 2025;135(20):e191824. https://doi.org/10.1172/JCI191824.
View: Text | PDF
Research Letter Genetics Pulmonology

Differential BK channel potentiation by vanzacaftor enantiomers enables therapy for modulator-ineligible people with cystic fibrosis

Abstract

Authors

Nathalie Baumlin, Sumedha Gunewardena, Scott H. Randell, Frank T. Horrigan, Matthias Salathe

×

Download this citation for these citation managers:

Or, download this citation in these formats:

If you experience problems using these citation formats, send us feedback.
Advertisement